Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

China Pharma Holdings (CPHI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,895
  • Shares Outstanding, K 43,580
  • Annual Sales, $ 13,210 K
  • Annual Income, $ -19,280 K
  • 36-Month Beta 2.39
  • Price/Sales 0.81
  • Price/Cash Flow N/A
  • Price/Book 0.24
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/21/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.20 +20.00%
on 06/28/18
0.27 -11.11%
on 07/16/18
+0.01 (+4.35%)
since 06/20/18
3-Month
0.20 +20.00%
on 06/28/18
0.32 -26.15%
on 04/23/18
-0.06 (-20.00%)
since 04/20/18
52-Week
0.15 +60.00%
on 10/18/17
1.45 -83.45%
on 01/05/18
+0.01 (+5.73%)
since 07/20/17

Most Recent Stories

More News
Free Stock Performance Review on Pfizer and Three More Drug Makers' Stocks

Stock Research Monitor: AZN, CPHI, and MRK

CPHI : 0.24 (-4.00%)
AZN : 37.17 (+0.38%)
PFE : 37.33 (-0.08%)
China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results

China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today...

CPHI : 0.24 (-4.00%)
CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET

China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans...

CPHI : 0.24 (-4.00%)
Wired News - Eli Lilly's Phase-3 REACH-2 Study of CYRAMZA(R) Met its Primary Endpoint of Overall Survival

Stock Monitor: China Pharma Holdings Post Earnings Reporting

CPHI : 0.24 (-4.00%)
LLY : 88.47 (-1.07%)
Blog Exposure - Tonix Pharma Announces 50% Enrolment in Tonmya® Study for PTSD

Stock Monitor: China Pharma Holdings Post Earnings Reporting

CPHI : 0.24 (-4.00%)
China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results

China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China, today...

CPHI : 0.24 (-4.00%)
CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET

China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans...

CPHI : 0.24 (-4.00%)
Quotidian Technical Highlights on Selected Drug Makers Stocks -- Aerie Pharma, AstraZeneca, China Pharma, and GlaxoSmithKline

WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on AERI, AZN, CPHI, and GSK which can be accessed for free by signing up to www.wallstequities.com/registration....

CPHI : 0.24 (-4.00%)
AERI : 73.40 (-0.68%)
AZN : 37.17 (+0.38%)
GSK : 41.87 (+2.90%)
CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET

China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced that it plans...

CPHI : 0.24 (-4.00%)
Corporate News Blog - GlaxoSmithKline Declares Publication of Phase-III Results Of Mepolizumab in Patients with Eosinophilic COPD at Risk of Exacerbations

Research Desk Line-up: China Pharma Post Earnings Coverage

CPHI : 0.24 (-4.00%)
GSK : 41.87 (+2.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade CPHI with:

Business Summary

CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson),...

See More

Key Turning Points

2nd Resistance Point 0.27
1st Resistance Point 0.25
Last Price 0.24
1st Support Level 0.22
2nd Support Level 0.21

See More

52-Week High 1.45
Fibonacci 61.8% 0.95
Fibonacci 50% 0.80
Fibonacci 38.2% 0.65
Last Price 0.24
52-Week Low 0.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar